State of Central Hemodynamics in Patients with Coronary Heart Disease and Diabetic Nephropathy

Karimov S. B.; Jabbarov O. O.; Alyavi A. L.; Umarova Z. F.; Tursunova L. D.; Xodjanova Sh. I.

Authors

Karimov S. B. Tashkent Medical Academy
Jabbarov O. O. Tashkent Medical Academy
Alyavi A. L. Tashkent Medical Academy
Umarova Z. F. Tashkent Medical Academy
Tursunova L. D. Tashkent Medical Academy
Xodjanova Sh. I. Tashkent Medical Academy

Vol. 2 No. 5 (2024): International Journal of Integrative and Modern Medicine

Articles

May 24, 2024

Downloads

View Article

Abstract
How to Cite
Metrics
References

This article highlights the role of diabetic nephropathy in the origin and course of ischemic heart disease.

S. B., K., O. O., J., A. L., A., Z. F., U., L. D., T., & Sh. I., X. (2024). State of Central Hemodynamics in Patients with Coronary Heart Disease and Diabetic Nephropathy. International Journal of Integrative and Modern Medicine, 2(5), 277–282. Retrieved from https://medicaljournals.eu/index.php/IJIMM/article/view/361

Download Citation

Bright R. Cases and observations, illustrative of renal disease, accompanied with the secretion of albuminous urine. Guy’s Hosp Trans. 1836:338–379.

Stevens PE, O’Donoghue DJ, de Lusignan S, Van Vlymen J, Klebe B, Middleton R, Hague N, New J, Farmer CK. Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int. 2007;72:92–99. doi: 10.1038/sj.ki.5002273 Crossref. PubMed.

Thompson S, James M, Wiebe N, Hemmelgarn B, Manns B, Klarenbach S, Tonelli M; Alberta Kidney Disease Network. Cause of death in patients with reduced kidney function. J Am Soc Nephrol. 2015;26:2504–2511. doi: 10.1681/ASN.2014070714 Crossref. PubMed.

Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. Lancet. 2017;389:1238–1252. doi: 10.1016/S0140-6736(16)32064-5 Crossref. PubMed.

Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(5 suppl 3):S112–S119. doi: 10.1053/ajkd.1998.v32.pm9820470 Crossref. PubMed.

Vanholder R, Argilés A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, et al. Uremic toxicity: present state of the art. Int J Artif Organs. 2001;24:695–725. doi: 10.1177/039139880102401004 Crossref. PubMed.

Kuo IY, Chapman AB. Polycystins, ADPKD, and cardiovascular disease. Kidney Int Rep. 2020;5:396–406. doi: 10.1016/j.ekir.2019.12.007 Crossref. PubMed.

National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1–266. PubMed.

Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67:2089–2100. doi: 10.1111/j.1523-1755.2005.00365.x Crossref. PubMed.

Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G; National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137–147. doi: 10.7326/0003-4819-139-2-200307150-00013 Crossref. PubMed.

Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150. doi: 10.1038/kisup.2012.76 Crossref.

Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. Chapter 1: definition and classification of CKD. Kidney Int Suppl (2011). 2013;3:19–62. doi: 10.1038/kisup.2012.64 Crossref. PubMed.

Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT; Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375:2073–2081. doi: 10.1016/S0140-6736(10)60674-5 Crossref. PubMed.

Arnlöv J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, Benjamin EJ, D’Agostino RB, Vasan RS. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation. 2005;112:969–975. doi: 10.1161/CIRCULATIONAHA.105.538132 Crossref. PubMed.

Mulè G, Castiglia A, Cusumano C, Scaduto E, Geraci G, Altieri D, Di Natale E, Cacciatore O, Cerasola G, Cottone S. Subclinical kidney damage in hypertensive patients: a renal window opened on the cardiovascular system. Focus on microalbuminuria. Adv Exp Med Biol. 2017;956:279–306. doi: 10.1007/5584_2016_85 Crossref. PubMed.

Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, Gansevoort RT, Kasiske BL, Eckardt KU. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011;80:17–28. doi: 10.1038/ki.2010.483 Crossref. PubMed.

Eckardt KU, Coresh J, Devuyst O, Johnson RJ, Köttgen A, Levey AS, Levin A. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet. 2013;382:158–169. doi: 10.1016/S0140-6736(13)60439-0 Crossref. PubMed.

Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, Hobbs FD. Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS One. 2016;11:e0158765. doi: 10.1371/journal.pone.0158765 Crossref. PubMed.

International Society of Nephrology. ISN Global Health Atlas. 2019. Accessed February 25, 2021. https://www.theisn.org/initiatives/global-kidney-health-atlas

United States Renal Data System, Annual Data Report. 2018. Accessed February 25, 2021. https://wwwusrdsorg/2018/view/v2_01aspx

International Journal of Integrative and Modern Medicine

State of Central Hemodynamics in Patients with Coronary Heart Disease and Diabetic Nephropathy

Authors

Downloads

Similar Articles

submenu

counter